Please contact us for more information or to learn if you are eligible to participate.
This study will evaluate the efficacy, safety, and pharmacokinetics of BFKB8488A compared with placebo in patients with non-alcoholic steatohepatitis (NASH).
Principal Investigator | Fernando Membreno, MD |
Co-PI | John Rodriguez |
Sponsor | Genentech, Inc. |
Type of Trial | Interventional |